Cochrane · systematic review · CD005943
Progestogen for treating threatened miscarriage
Wahabi, HA, Fayed, AA, Esmaeil, SA, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library
Pregnancy and ChildbirthAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 33.3%Low 1 · 33.3%Moderate 1 · 33.3%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Progesterone compared to placebo or no treatment for treating threatened miscarriage
Population: women with threatened miscarriage
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Miscarriage Progesterone vs placebo or no treatment | RR 0.64 [0.47, 0.87] | 7 studies · 696 participants | Moderate Downgraded: risk of bias |
Preterm birth Progesterone vs placebo or no treatment | RR 0.86 [0.52, 1.44] | 5 studies · 588 participants | Low Downgraded: risk of bias, imprecision |
Congential abnormalities Progesterone vs placebo or no treatment | RR 0.7 [0.1, 4.82] | 2 studies · 337 participants | Very low Downgraded: risk of bias, imprecision |